Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.73
-0.20 (-2.52%)
At close: Apr 28, 2026, 4:00 PM EDT
7.67
-0.06 (-0.78%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Adicet Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Adicet Bio stock have an average target of 48.33, with a low estimate of 18 and a high estimate of 100. The average target predicts an increase of 525.23% from the current stock price of 7.73.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 23, 2026.
Analyst Ratings
The average analyst rating for Adicet Bio stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $27 | Strong Buy | Maintains | $50 → $27 | +249.29% | Mar 23, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $128 → $100 | Strong Buy | Maintains | $128 → $100 | +1,193.66% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $50 | Strong Buy | Maintains | $9 → $50 | +546.83% | Jan 21, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $128 → $18 | Strong Buy | Maintains | $128 → $18 | +132.86% | Jan 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $64 → $144 | Strong Buy | Maintains | $64 → $144 | +1,762.87% | Nov 7, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-10.43
from -16.95
EPS Next Year
-10.13
from -10.43
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -5.73 | -4.23 | ||||||
| Avg | -10.43 | -10.13 | ||||||
| Low | -12.70 | -17.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.